Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells

M.D. Wissing; J. Mendonca; E. Kim; J.S. Shim; N.S. Kaelber; H. Kant; H. Hammers; T. Commes; P.J. van Diest; J.O. Liu; S.K. Kachhap

doi:10.4161/cbt.23759

Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells

M.D. Wissing, J. Mendonca, E. Kim, J.S. Shim, N.S. Kaelber, H. Kant, H. Hammers, T. Commes, P.J. van Diest, J.O. Liu, S.K. Kachhap

Medical oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	401-410
Journal	Cancer Biology and Therapy
Volume	14
Issue number	5
DOIs	https://doi.org/10.4161/cbt.23759
Publication status	Published - 2013

Access to Document

10.4161/cbt.23759

Cite this

Wissing, M. D., Mendonca, J., Kim, E., Shim, J. S., Kaelber, N. S., Kant, H., Hammers, H., Commes, T., van Diest, P. J., Liu, J. O., & Kachhap, S. K. (2013). Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells. Cancer Biology and Therapy, 14(5), 401-410. https://doi.org/10.4161/cbt.23759

@article{115c27dfb446401382a3618fe27db63d,

title = "Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells",

author = "M.D. Wissing and J. Mendonca and E. Kim and J.S. Shim and N.S. Kaelber and H. Kant and H. Hammers and T. Commes and {van Diest}, P.J. and J.O. Liu and S.K. Kachhap",

year = "2013",

doi = "10.4161/cbt.23759",

language = "Undefined/Unknown",

volume = "14",

pages = "401--410",

journal = "Cancer Biology and Therapy",

issn = "1538-4047",

number = "5",

}

Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells. / Wissing, M.D.; Mendonca, J.; Kim, E.; Shim, J.S.; Kaelber, N.S.; Kant, H.; Hammers, H.; Commes, T.; van Diest, P.J.; Liu, J.O.; Kachhap, S.K.

In: Cancer Biology and Therapy, Vol. 14, No. 5, 2013, p. 401-410.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells

AU - Wissing, M.D.

AU - Mendonca, J.

AU - Kim, E.

AU - Shim, J.S.

AU - Kaelber, N.S.

AU - Kant, H.

AU - Hammers, H.

AU - Commes, T.

AU - van Diest, P.J.

AU - Liu, J.O.

AU - Kachhap, S.K.

PY - 2013

Y1 - 2013

U2 - 10.4161/cbt.23759

DO - 10.4161/cbt.23759

M3 - Article

C2 - 23377825

VL - 14

SP - 401

EP - 410

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 5

ER -